Medication Monitor



Generic Name (Trade Name—Company)
Notes
June 10, 2011

Various products

(Various trade names—Merck)
Some Merck drugs getting redesigned labels

FDA has approved Merck’s redesigned drug container labels that were developed under Merck’s Label Standardization Project. The labels will include a new standardized format to improve readability and provide better information on product and strength differentiation. The project includes the revision of 34 container labels for 16 oral products. The drugs affected include Cozaar, Crixivan, Hyzaar, Isentress, Janumet, Januvia, Mevacor, Noroxin, Prinivil, Prinizide, Propecia, Proscar, Singulair, Zocor, and Zolinza.